1887

Abstract

Neurological dysfunction in AIDS occurs in the absence of productive infection of neurons, and may involve modulation of neuronal cell function by viral or cellular products released from surrounding infected cells. The human immunodeficiency virus type 1 (HIV-1) transactivator protein Tat may be one such factor, as it can act as a neurotoxin, induces marked morphological changes in neurons and astrocytes in primary embryonic rodent brain cultures, and is released by certain HIV-1-infected cells. In addition, Tat can alter expression of cellular genes in several non-neuronal cell types. To explore the possibility that Tat may also mediate neuronal dysfunction in AIDS through non-lethal effects on neurons, we determined the trans-activating ability of Tat in human neuronal cells. We generated human neuronal cell lines stably expressing several HIV-1 genes, and also tested human neuronal cells exposed to extracellular recombinant Tat protein. Both endogenously expressed Tat as well as exogenous recombinant Tat protein up-regulated HIV-1 long terminal region (LTR)-driven gene expression by several hundred-fold. Only brief exposure to recombinant Tat was necessary and no toxic effects were seen at levels sufficient for trans-activation. Furthermore, Tat significantly enhanced virus expression in neuronal cells transfected with molecular clones of HIV-1. These results show that Tat is trans-activationally active in human neuronal cells, and can be taken up from the extracellular compartment by these cells in a biologically active form. Neurons represent an important potential target for Tat-mediated cellular dysfunction.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-75-8-1927
1994-08-01
2022-05-28
Loading full text...

Full text loading...

/deliver/fulltext/jgv/75/8/JV0750081927.html?itemId=/content/journal/jgv/10.1099/0022-1317-75-8-1927&mimeType=html&fmt=ahah

References

  1. Achim C., Schrier R., Wiley C. 1991; Immunopathogenesis of HIV encephalitis. Brain Pathology 1:177–184
    [Google Scholar]
  2. Aldovini A., Debouck C., Feinberg M. B., Rosenberg M., Arya S. K., Wong-Staal F. 1986; Synthesis of the complete trans-activation gene product of human T-lymphotropic virus type III in Escherichia coli: demonstration of immunogenicity in vivo and expression in vitro. Proceedings of the National Academy of Sciences, U.S.A 83:6672–6676
    [Google Scholar]
  3. Bacheler L. T., Strehl L. L., Neubauer R. H., Petteway S. R., Ferguson B. Q. 1989; Stable indicator cell lines exhibiting HIV-1 Tat function. AIDS Research and Human Retroviruses 5:275–278
    [Google Scholar]
  4. Bagasara O., Khalili K., Seshamma T., Taylor J. P., Pomerantz R. J. 1992; TAR-independent replication of human immunodeficiency virus type 1 in glial cells. Journal of Virology 66:7522–7528
    [Google Scholar]
  5. Beidler J. L., Helson L., Spengler B. 1973; Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Research 33:2643–2652
    [Google Scholar]
  6. Beidler J. L., Roffler-Tarlov S., Schachner M., Freedman L. S. 1978; Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Research 38:3751–3757
    [Google Scholar]
  7. Buonaguro L., Barillari G., Chang H. K., Bohan C. A., Kao V., Morgan R., Gallo R. C., Ensoli B. 1992; Effects of the human immunodeficiency virus type 1 Tat protein on the expression of inflammatory cytokines. Journal of Virology 66:7159–7167
    [Google Scholar]
  8. Collman R., Balliet J. W., Gregory S. A., Friedman H., Kolson D. L., Nathanson N., Srinivasan A. 1992; An infectious molecular clone of an unusual macrophage-tropic and highly cytopathic strain of human immunodeficiency virus type 1. Journal of Virology 66:7517–7521
    [Google Scholar]
  9. Corboy J. R., Buzy J. M., Zink M. C., Clemens J. E. 1992; Expression directed from HIV long terminal repeats in the central nervous system of transgenic mice. Science 258:1804–1808
    [Google Scholar]
  10. Cupp C., Taylor J. P., Khalili K., Amini S. 1993; Evidence for stimulation of the transforming growth factor (β1 promoter by HIV-1 Tat in cells derived from CNS. Oncogene 8:2231–2236
    [Google Scholar]
  11. Ensoli B., Barillari G., Salahuddin S. 1990; Tat protein of HIV-1 stimulates growth of cells derived from Kaposi’s sarcoma lesions of AIDS patients. Nature; London: 34584–86
    [Google Scholar]
  12. Ensoli B., Buonaguro L., Barillari G., Fiorelli V., Gendelman R., Morgan R., Wingfield P., Gallo R. 1992; Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. Journal of Virology 67:277–287
    [Google Scholar]
  13. Frankel A. D., Pabo C. 1988; Cellular uptake of the Tat protein from human immunodeficiency virus. Cell 55:1189–1193
    [Google Scholar]
  14. Frankel A. D., Biancalana S., Fiudson D. 1989; Activity of synthetic peptides from the Tat protein of human immunodeficiency virus type 1. Proceedings of the National Academy of Sciences, U.S.A 86:7397–7401
    [Google Scholar]
  15. Gabudza D., Flo D., de la Monte S., Hirsch M., Rota T., Sobel R. 1987; Immunohistochemical identification of FITLV-III antigens in brains of patients with acquired immunodeficiency syndrome. Annals of Neurology 20:289–295
    [Google Scholar]
  16. Genis P., Jett M., Bernton E., Boyle T., Gelbard H., Dzenko K., Keane R., Resnick L., Mizrachi Y., Volsky D., Epstein L., Gendelman H. 1992; Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV disease. Journal of Experimental Medicine 176:1703–1718
    [Google Scholar]
  17. Giulian D., Vaca K., Noonan C. 1990; Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1. Science 250:1593–1596
    [Google Scholar]
  18. Gorman M., Moffat L. F., Howard B. H. 1982; Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Molecular and Cellular Biology 2:1044–1051
    [Google Scholar]
  19. Green M., Lowenstein P. 1990; Autonomous functional domains of chemically synthesized human immunodeficiency virus Tat transactivator protein. Cell 55:1179–1188
    [Google Scholar]
  20. Harouse J., Bhat S., Spitalnik S., Laughlin M., Stefano K., Silberberg D., Gonzalez-Scarano F. 1991; Inhibition of entry of HIV-1 in neural cell lines by antibodies against galacto-sylceramide. Science 253:320–323
    [Google Scholar]
  21. Helland D., Welles J., Caputo A., Haseltine W. 1991; Transcellular transactivation by the human immunodeficiency virus type 1 Tat protein. Journal of Virology 65:4547–4549
    [Google Scholar]
  22. Howcroft T. K., Strevel K., Martin M. A., Singer D. S. 1993; Repression of MHC class I gene promoter activity by two-exon Tat of HIV. Science 260:1320–1322
    [Google Scholar]
  23. Kato T., Hirano A., Llena J., Dembitzer H. 1987; Neuropathology of acquired immune deficiency syndrome (AIDS) in 53 autopsy cases with particular emphasis on microglial nodules and multinucleated giant cells. Actaneuropathologica 73:287–294
    [Google Scholar]
  24. Koenig S., Gendelman H., Orenstein J., Dal Canto M., Pezeshkpour G. 1986; Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 223:1089–1093
    [Google Scholar]
  25. Kolson D. L., Buchhalter J., Collman R., Hellmig B., Farrell C., Debouck C., Gonzalez-Scarano F. 1993; HIV-1 Tat alters normal organization of neurons and astrocytes in primary rodent brain cell cultures: RGD sequence dependence. AIDS Research and Human Retroviruses 9:677–685
    [Google Scholar]
  26. Kolson D. L., Debouck C., Collman R. C., Gonzalez-Scarano F. 1994; Functional assay for Tat, the transactivator protein of HIV-1. In Methods in Molecular Genetics 4 Molecular Virology Adolph K. W. Edited by San Diego: Academic Press; in press
    [Google Scholar]
  27. Kure K., Llena J. F., Lyman W. D., Soeiro R., Weidenheim K. M., Hirano A., Dickson D. 1990; HIV-1 infection of the nervous system: an autopsy study of 268 adult, pediatric, and fetal brains. Human Pathology 22:100–122
    [Google Scholar]
  28. Levy J. A. 1993; Pathogenesis of HIV infection. Microbiological Reviews 57:183–289
    [Google Scholar]
  29. Li X., Moudgil T., Vinters H., Ho D. 1990; CD4-independent, productive infection of a neuronal cell line by human immunodeficiency virus type 1. Journal of Virology 64:1383–1387
    [Google Scholar]
  30. Lipton S. 1991; HIV-related neurotoxicity. Brain Pathology 1:193–199
    [Google Scholar]
  31. Mann D., Frankel A. 1991; Endocytosis and targeting of exogenous HIV-1 Tat protein. EMBO Journal 10:1733–1739
    [Google Scholar]
  32. Marcuzzi A., Weinberger J., Weinberger O. K. 1992a; Transcellular activation of the human immunodeficiency virus type 1 long terminal repeat in cocultured lymphocytes. Journal of Virology 66:4228–4232
    [Google Scholar]
  33. Marcuzzi A., Weinberger J., Weinberger O. K. 1992b; Transcellular activation of the human immunodeficiency virus type 1 long terminal repeat in T lymphocytes requires CD4-gp120 binding. Journal of Virology 66:4536–4539
    [Google Scholar]
  34. Merrill J., Koyanagi Y., Chen I. 1989; Interleukin-1 and tumor necrosis factor a can be induced from mononuclear phagocytes by human immunodeficiency virus type 1 binding to the CD4 receptor. Journal of Virology 63:4404–4408
    [Google Scholar]
  35. Merrill J., Koyanagi Y., Zack J., Thomas L., Martin A., Chen I. 1992; Induction of interleukin-1 and tumor necrosis factor alpha in brain cultures by human immunodeficiency virus type 1. Journal of Virology 66:2217–2225
    [Google Scholar]
  36. Molina J., Schindler R., Ferriani R., Sakaguchi M., Vannier E., Dinarello C. A., Groopman J. E. 1990; Production of cytokines by peripheral blood monocytes/macrophages infected with human immunodeficiency virus type 1 (HKV-1). Journal of Infectious Diseases 161:888–893
    [Google Scholar]
  37. Navia B., Cho E., Petito C., Price R. 1986; The AIDS dementia complex. II. Neuropathology. Annals of Neurology 19:525–535
    [Google Scholar]
  38. Neumann J., Morency D., Russian K. 1987; A novel rapid assay for chloramphenicol acetyltransferase gene expression. Biotechniques 5:444–447
    [Google Scholar]
  39. Peterlin B. M., Luciw P. A., Barr P. J., Walker M. D. 1986; Elevated levels of mRNA can account for the trans-activation of human immunodeficiency virus. Proceedings of the National Academy of Sciences, U.S.A 83:9734–9783
    [Google Scholar]
  40. Pulliam L., Herndier B., Tang N. 1991; Human immunodeficiency virus-infected macrophages produce soluble factors that cause histological and neurochemical alterations in cultured human brains. Journal of Clinical Investigation 87:503–512
    [Google Scholar]
  41. Pumarola-Sune T., Navia B., Cordon-Cardo C. 1987; HIV antigen in the brains of patients with AIDS dementia complex. Annals of Neurology 21:490–496
    [Google Scholar]
  42. Puri R. K., Aggarwal B. B. 1992; Human Immunodeficiency virus type 1 Tat gene upregulates interleukin 4 receptors on a human B-lymphoblastoid cell line. Cancer Research 52:3787–3790
    [Google Scholar]
  43. Rattner A., Korner M., Walker M. D., Citri Y. 1993; NF-KB activates the HIV promoter in neurons. EMBO Journal 12:4261–4267
    [Google Scholar]
  44. Sabatier J., Vives E., Mabrouk K., Benjouad A., Rochat H., Duval A., Hue B., Bahraoui E. 1991; Evidence for neurotoxic activity of Tat from human immunodeficiency virus type 1. Journal of Virology 65:961–967
    [Google Scholar]
  45. Sastry K. J., Reddy R. H. R., Pandita R., Totpal K., Aggarwal B. B. 1990; HIV-1 Tat gene induces tumor necrosis factor-β (lymphotoxin) in a human B-lymphoblastoid cell line. Journal of Biological Chemistry 265:20091–20093
    [Google Scholar]
  46. Shaw G. M., Hahn B. H., Aryp S. K., Groopman J. E., Gallo R. C., Wong-Staal F. 1984; Molecular characterization of human T-cell leukemia (lymphotropic) virus type III in the acquired immune deficiency syndrome. Science 226:1165–1171
    [Google Scholar]
  47. Spencer D. C., Price R. W. 1992; HIV and the central nervous system. Annual Review of Microbiology 46:655–693
    [Google Scholar]
  48. Stefano K., Collman R., Kolson D., Hoxie J., Nathanson N., Gonzalez-Scarano F. 1993; Replication of a macrophage-tropic strain of type 1 human immunodeficiency virus in a hybrid cell line, CEMx174 suggests that cellular accessory molecules are required for HIV entry. Journal of Virology 67:6707–6715
    [Google Scholar]
  49. Swingler S., Easton A., Morris A. 1992; Cytokine augmentation of HIV-1 driven gene expression in neural cells. AIDS Research and Human Retroviruses 8:487–493
    [Google Scholar]
  50. Tardieu M., Hery C., Peudenier S., Boespflug O., Montagnier L. 1992; Human immunodeficiency virus type 1-infected monocytic cells can destroy human neural cells after cell-to-cell adhesion. Annals of Neurology 32:11–17
    [Google Scholar]
  51. Taylor J. P., Cupp C., Diaz A., Chowdhury M., Khalili K., Jimenez S. A., Amini S. 1992; Activation of expression of genes coding for extracellular matrix proteins in Tat-producing glioblastoma cells. Proceedings of the National Academy of Sciences, U.S.A 89:9617–9621
    [Google Scholar]
  52. Ursini M. V., Lettieri T., Braddock M., Martin G. 1993; Enhanced activity of human G6PD promoter transfected in HeLa cells producing high levels of HIV-1 Tat. Virology 196:338–343
    [Google Scholar]
  53. Wiley C., Schrier R., Nelson J., Lampert P., Oldstone M. 1986; Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proceedings of the National Academy of Sciences, U.S.A 83:7089–7093
    [Google Scholar]
  54. Zauli G., Davis B. R., Re M. C., Visani G., Giuliano F., La Placa M. 1992; Tat protein stimulates production of transforming growth factor-β1 by marrow macrophages: a potential mechanism for human immunodeficiency virus-1-induced hematopoietic suppression. Blood 12:3036–3043
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-75-8-1927
Loading
/content/journal/jgv/10.1099/0022-1317-75-8-1927
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error